Targeting estrogen to kill ER-positive and ER-negative breast cancer

被引：0
|
作者：
Jordan, VC [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
BREAST CANCER RESEARCH | 2005年 / 7卷 / Suppl 2期
关键词：
D O I：
10.1186/bcr1053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [41] Restoration of ER expression and antiestrogen response in ER-negative breast cancer
    Bayliss, Jill
    Hilger, Amy
    El-Ashry, Dorraya
    CANCER RESEARCH, 2006, 66 (08)
  • [42] Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
    Anna R. Michmerhuizen
    Lynn M. Lerner
    Andrea M. Pesch
    Connor Ward
    Rachel Schwartz
    Kari Wilder-Romans
    Meilan Liu
    Charles Nino
    Kassidy Jungles
    Ruth Azaria
    Alexa Jelley
    Nicole Zambrana Garcia
    Alexis Harold
    Amanda Zhang
    Bryan Wharram
    Daniel F. Hayes
    James M. Rae
    Lori J. Pierce
    Corey W. Speers
    npj Breast Cancer, 8
  • [43] Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer
    Patani, Neill
    Dunbier, Anita K.
    Anderson, Helen
    Ghazoui, Zara
    Ribas, Ricardo
    Anderson, Elizabeth
    Gao, Qiong
    A'hern, Roger
    Mackay, Alan
    Lindemann, Justin
    Wellings, Robert
    Walker, Jill
    Kuter, Irene
    Martin, Lesley-Ann
    Dowsett, Mitch
    CLINICAL CANCER RESEARCH, 2014, 20 (15) : 3962 - 3973
  • [44] Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis
    Gan, Siyuan
    Dai, Haixia
    Li, Rujia
    Liu, Wang
    Ye, Ruifang
    Ha, Yanping
    Di, Xiaoqing
    Hu, Wenhua
    Zhang, Zhi
    Sun, Yanqin
    GLAND SURGERY, 2020, 9 (03) : 661 - 675
  • [45] Late recurrence in ER-positive breast cancer
    Gralow, J.
    CANCER RESEARCH, 2019, 79 (04)
  • [46] Renalase overexpression in ER-positive breast cancer
    Yu, Xuewen
    Han, Pengxun
    Wang, Jiachuan
    Sun, Huili
    Shao, Mumin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (03): : 1297 - 1307
  • [47] The role of the AR/ER ratio in ER-positive breast cancer patients
    Rangel, Nelson
    Rondon-Lagos, Milena
    Annaratone, Laura
    Osella-Abate, Simona
    Metovic, Jasna
    Mano, Maria Piera
    Bertero, Luca
    Cassoni, Paola
    Sapino, Anna
    Castellano, Isabella
    ENDOCRINE-RELATED CANCER, 2018, 25 (03) : 163 - 172
  • [48] Multiple mechanisms of estrogen receptor gene repression contribute to ER-negative breast cancer
    Parl, FF
    PHARMACOGENOMICS JOURNAL, 2003, 3 (05): : 251 - 253
  • [49] Apocrine metaplasia and the development of ER-negative breast cancer
    Lee, S
    Mohsin, SK
    Weiss, H
    Medina, D
    Allred, DC
    LABORATORY INVESTIGATION, 2005, 85 : 40A - 40A
  • [50] Distinct p53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers
    Coutant, Charles
    Rouzier, Roman
    Qi, Yuan
    Lehmann-Che, Jacqueline
    Bianchini, Giampaolo
    Iwamoto, Takayuki
    Hortobagyi, Gabriel N.
    Symmans, W. Fraser
    Uzan, Serge
    Andre, Fabrice
    de The, Hugues
    Pusztai, Lajos
    CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2591 - 2601
12345